ImmunologybioRxivPreprint
SIGLEC1 FACILITATES MACROPHAGE-CD8+ T CELL INTERACTIONS AND CORRELATES WITH CANCER IMMUNOTHERAPY RESPONSE
Sofía Ibáñez Molero, Magalí B. Coccimiglio, Babet O. Springer…·Yvette van Kooyk
This study identifies SIGLEC1 as a mediator of macrophage-CD8+ T cell interactions in melanoma and shows its correlation with response to immune checkpoint blockade.
DOI 10.64898/2026.07.09.737484